期刊文献+

妈富隆联合二甲双胍治疗肥胖型青春期多囊卵巢综合征30例疗效观察 被引量:8

Clinical observation of marvelon combined with metformin in the treatment of 30 cases of pubertal polycystic ovary syndrome
下载PDF
导出
摘要 目的观察妈富隆联合二甲双胍治疗肥胖型青春期多囊卵巢综合征患者内分泌代谢紊乱的疗效。方法对30例肥胖型青春期多囊卵巢综合征患者给予妈富隆联合二甲双胍治疗3个月,观察治疗前后性激素指标、糖代谢指标、体重指数、面部痤疮评分等变化情况。结果患者LH、T及LH/FSH比值均较治疗前下降(P<0.05),FSH、E2、PRL、P及空腹血糖则无明显变化(P>0.05),空腹胰岛素、葡萄糖曲线下面积下降(P<0.05),胰岛素曲线下面积、HOMA-IR明显下降(P<0.01);体重指数及腰臀比下降。结论妈富隆联合二甲双胍对降低肥胖型青春期多囊卵巢综合征雄激素水平,改善胰岛素抵抗,恢复正常月经周期有明显效果。 Objective To study the clinical efficacy of marvelon combined with metformin in the treatment of pubertal polyeystic ovarian syndrome: effect of endocrine and metabolic disorders. Methods Thirty obese adoles- cent girls with polycystic ovarian syndrome were given marvelon combined with metformin for 3 months. The sex hor- mone indexes, indices of glucose metabolism, body mass index, facial acne score changes were observed before and after treatment. Results After treatment, LH, T and LH / FSH ratio decreased than that before treatment (P〈0.05), while FSH, E2, PRL, P and fasting glucose showed no significant change (P〉0.05). The area under fasting insulin curve and glucose curve decreased significantly (P〈0.05), and the area under the insulin curve was marked significant- ly decreased (P〈0.01). The insulin resistance index of HOMA-IR decreased significantly (P〈0.01), and the body mass index and waist-hip ratio also declined. Conclusion Marvelon combined with metformin is quite effective in reduc- ing obesity of pubertal polycystic ovary syndrome and androgen levels, improving insulin resistance and recovering normal menstrual cycles.
出处 《海南医学》 CAS 2012年第15期76-78,共3页 Hainan Medical Journal
关键词 青春期 多囊卵巢综合征 肥胖型 二甲双胍 妈富隆 Puberty Polycystic ovarian syndrome Obesity Metformin Marvelon
  • 相关文献

参考文献6

  • 1The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Work shop Group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome [J]. Fertil Steril, 2004, 81(1): 19-25.
  • 2倪仁敏,杨冬梓.胰岛素抵抗与PCOS代谢综合征[J].实用妇产科杂志,2010,26(8):566-568. 被引量:23
  • 3曹泽毅.多囊卵巢综合征[M].2版.北京:人民卫生出版社,2004:2448-2479.
  • 4石晓敏,周怀君.青春期多囊卵巢综合征(PCOS)的月经特征分析[J].实用临床医药杂志,2009,13(7):105-106. 被引量:8
  • 5Trent M, Austin SB, Rich M, et al. Overweight status of adolescent girls with polycystic ovary syndrome: hodymass index as mediator of quality of life [J]. Ambul Pediatr, 2005, 5(2): 107-111.
  • 6李丽.妈富隆联合二甲双胍治疗青春期多囊卵巢综合征500例疗效观察[J].中外健康文摘,2010,38(7):94-95.

二级参考文献15

  • 1The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group.Revised 2003 consensus on diagnostic criteria and long-term herlth risks related to polycystic ovary syndrome (PCOS)[J].Hum Reprod,2004,19(1):41.
  • 2Sultan C,Paris F.Clinical expression of polycystic ovary syndrome in adolescent girls[J].Fertil Steril,2006,86(1):S6.
  • 3Bridges N A,Cooke A,Healy M J,et al.Standards for ovarian volume in childhood and puberty[J].Fertil Steril,1993,60(3):456.
  • 4Abbott D H,Dumesic D A,Franks S.Developmental origin of polycystictic ovary syndrome-a hypothesis[J].J Endocrinol,2002,174(1):1.
  • 5VanHoom,M H A,Voorhorst F J,et al.Predictive value ofmenstrual cycle pattern,body mass index,hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years[J].Human Reproduction,2004,19(2):383.
  • 6Goldzieher J W.Axelrod L R Clinical and biochemical features of polycystic ovarian disease[J].Fertil Steril,2004,14:631.
  • 7Ferriman D,Purdie A W.The aetiology of oligomenorrhoea and/or hirsuties:a study of 467 patients[J].Postgrad Med J,2004,59:17.
  • 8Falsetti L,Eleftheriou G.Hyperinsulinemia in the polycystic ovary syndrome:a clinical,endocrine and echographic study in 240 patients[J].Gynecol Endocrinol,2004,10:319.
  • 9Khoury M Y,Baracat E C,Pardini D P,et al.Polycystic ovary syndrome:clinical and laboratory evaluation[J].Sao Paulo Med J,1998,114:1222.
  • 10Alberti KG,Zimmet P,Shaw J.Metabolic syndrome-a new world -wide definition.A consensus statement from the international diabetes federation[J].Diabetic Medicine,2006,3(5):469 -480.

共引文献30

同被引文献91

  • 1梁竹巍,王蕊.二甲双胍治疗多囊卵巢综合征新进展[J].国外医学(妇产科学分册),2006,33(6):414-417. 被引量:19
  • 2曹泽毅.中华妇产科学[M].北京:人民卫生出版社,2004.2170-2172.
  • 3The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Work shop Group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome[J]. Fertil Steril,2004,81 (1): 19-25.
  • 4Karolyi Z. The pathomechanism of polycystic ovary syndrome in the light of recent research findings [ J]. Orv Hetil, 2012,153 (40) :1567 - 1569.
  • 5Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the poly- cystic ovary syndrome revisited : an update on mechanisms and im- plications[J]. Endocr Rev,2012,33(6) :981 -1030.
  • 6Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long- term health risks related to polycystic ovary syndrome [ J ]. Fertil Steri1,2004,81 ( 1 ) : 19 - 25.
  • 7Bhathena RK. Insulin resistance and the long-term consequences of polycystic ovary syndrome [ J]. J Obstet Gynaecol, 2011,31 (2) : 105 - 110.
  • 8Nawrocka-Rutkowska J, Cie6 wiez S, Marciniak A, et al. Insulin re- sistance assessment in patients with polycystic ovary syndrome u- sing different diagnostic criteria-impact of metformin treatment [ J l. Ann Agric Environ Med ,2013,20( 3 ):528 -532.
  • 9Costello MF, Misso ML, Wong J, et al. The treatment of infertility in polyeystie ovary syndrome : a brief update [ J ]. Aust N Z J Obstet Gynaeeo1,2012,52(4 ) :400 - 403.
  • 10Ghaz, eeri GS, Nassar AH, Younes Z, et al. Pregnancy outcomes and the effect of mefformin treatment in women with polyeystic ovary syndrome : an overview [ J]. Acta Obstet Gynecol Scand, 2012,91 (6) :658 -678.

引证文献8

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部